MoonLake Immunotherapeutics (MLTX) and Ferguson Enterprises (FERG) are among Tuesday’s top-performing US stocks rising double-digits in the charts. While MLTX surged nearly 15% minutes after the opening bell, FERG spiked close to 14% during the same timeframe.

Both the leading US stocks have rallied more than 10% in the last 30 trading sessions. While MLTX soared 13% in a month, FERG shot up 20% in 30 days. An investment of $1,000 made in May last month could have turned into $1,130 and $1,200, respectively.

Also Read: Credo Technology (CRDO) Stock Turns Tuesday’s Top Performer: Rises 25%

Top-Performing US Stocks on Tuesday: MLTX & FERG

Apart from MLTX and FERG, Credo Technology stock is the biggest gainer as it spiked 25% after the opening bell. The Q4 earnings were out today and delivered better-than-expected results. The firm generated a revenue of $170 million in Q4 compared to $135 million in Q3. The development made CRDO surge 25% and is attracting heavy bullish sentiments in the indices.

Also Read: Buffett Dumps BoA for Stock That Soared 7,700%

MLTX & FERG are now attracting buying pressure and their price remains affordable to the average investor. FERG is hovering around the $206 level and MLTX is moving at the $49 price range. The two leading US stocks are well below the $250 mark making it a low-hanging fruit to average investors.

Taking an entry position now when the MLTX and FERG stocks are below the $250 range could prove beneficial. Taking an entry position now and holding on for the long term might make investors’ portfolios swell. Buying now and waiting for the next five or 10 years could make a huge difference in terms of profits.

TipRanks predicts that MLTX could reach a high of $100 in the next 12 months. In addition, the same analytical firm forecasts that FERG could reach $220 during the same period. Therefore, both MLTX and FERG stocks could generate profits in a year.